View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Brookfield Infrastructure to Host Third Quarter 2025 Results Conferenc...

Brookfield Infrastructure to Host Third Quarter 2025 Results Conference Call BROOKFIELD, NEWS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners will hold its third quarter 2025 conference call and webcast on Friday, November 7, 2025, at 9:00 a.m. (ET). Results will be released that morning before 7:00 a.m. (ET) and will be available on our website at . Participants can join by conference call or webcast. Conference Call Please pre-register at: Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the ...

Anish Jog ... (+6)
  • Anish Jog
  • Daniel Ives
  • Matthew Weiss
  • Sam Brandeis
  • Scott Devitt
  • Steven Wahrhaftig

M&A Set to Accelerate In Tech As AI Revolution Takes Hold; Top Tech Ta...

Figure 1: What Will the M&A Landscape Look Like Over the Next Decade?Source: Wedbush Securities, Inc.Funding Remains Strong Across Private AI Markets. With the AI Revolution hitting its next gear of growth, more AI companies across the public and private markets are starting to gain significant

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PEGA PEGASYSTEMS INC.
PANW PALO ALTO NETWORKS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
IMAX IMAX CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
LAC. LITHIUM AMERICAS CORP NEW
ORKA ORUKA THERAPEUTICS INC
ZBIO ZENAS BIOPHARMA INC.
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
 PRESS RELEASE

FutureFuel Announces Director Resignation

FutureFuel Announces Director Resignation BATESVILLE, Ark., Sept. 29, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) ("FutureFuel” or the "Company”), a manufacturer of custom and performance chemicals and biofuels, announced today that Terrance C.Z. Egger, a member of the Board of Directors (the “Board”) of the Company, has determined not to stand for re-election to the Board at the Company’s 2025 annual meeting, which is set for November 11, 2025 (the “Annual Meeting”), and to thereby retire from the Board effective as of the Annual Meeting. Prior to his resignation, Mr. Egger serv...

 PRESS RELEASE

Brookfield Infrastructure to Issue $700 Million of Medium-Term Notes

Brookfield Infrastructure to Issue $700 Million of Medium-Term Notes All amounts in Canadian dollars unless otherwise stated NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES BROOKFIELD, News, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN) (“Brookfield Infrastructure”) today announced that it has agreed to issue $700 million aggregate principal amount of medium-term notes (the “Notes”), comprised of $375 million aggregate principal amount of Series 15 Notes, due January 6, 2031, which will bear i...

Anish Jog ... (+10)
  • Anish Jog
  • Daniel Ives
  • Kade Barr
  • Matthew Bryson
  • Matthew McCartney
  • Matthew Weiss
  • Sam Brandeis
  • Scott Devitt
  • Seth Basham
  • Steven Wahrhaftig
 PRESS RELEASE

FutureFuel Releases Second Quarter 2025 Results

FutureFuel Releases Second Quarter 2025 Results Reports Net Loss of $10.4 Million or $0.24 per Diluted Share, and Adjusted EBITDA of ($9.8) Million CLAYTON, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter ended June 30, 2025. Second quarter 2025 Financial Highlights (all comparisons are with the second quarter of 2024) Revenues were $35.7 million, a decrease of 51% or $36.7 million compared to $72.4 million.Net loss wa...

 PRESS RELEASE

Brookfield Infrastructure Reports Solid Second Quarter 2025 Results

Brookfield Infrastructure Reports Solid Second Quarter 2025 Results BROOKFIELD, News, July 31, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the second quarter ended June 30, 2025. “We had an active second quarter with our capital recycling strategy. We made three marquee acquisitions and also generated substantial proceeds from asset sales,” said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure. “Our ability to consistently buy high-quality as...

Daniel Ives ... (+3)
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig

PEGA 2Q25 Earnings; Strong Cloud ACV Growth Leading the Way; PT to $70

A Closer Look at FY2Q25 (June) ResultsRevenueTotal revenue increased 9% y/y to $384.5 million, which was well above the Street’s expectation of $362.5 million driven by elevated enthusiasm for Pega Blueprint and its AI suite.Total ACV grew 16% y/y (14% y/y in CC) to $1.51 billion, above the Street’

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch